[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2167169B2 - Carpule à double chambre dotée d'un chapiteau - Google Patents

Carpule à double chambre dotée d'un chapiteau Download PDF

Info

Publication number
EP2167169B2
EP2167169B2 EP08758924.8A EP08758924A EP2167169B2 EP 2167169 B2 EP2167169 B2 EP 2167169B2 EP 08758924 A EP08758924 A EP 08758924A EP 2167169 B2 EP2167169 B2 EP 2167169B2
Authority
EP
European Patent Office
Prior art keywords
pro
exendin
des
asp
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP08758924.8A
Other languages
German (de)
English (en)
Other versions
EP2167169A1 (fr
EP2167169B1 (fr
Inventor
Werner Seiferlein
Jörn Möckel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38621207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2167169(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Priority to EP08758924.8A priority Critical patent/EP2167169B2/fr
Publication of EP2167169A1 publication Critical patent/EP2167169A1/fr
Application granted granted Critical
Publication of EP2167169B1 publication Critical patent/EP2167169B1/fr
Publication of EP2167169B2 publication Critical patent/EP2167169B2/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
    • A61M2005/31506—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit formed as a single piece, e.g. moulded
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture

Definitions

  • Two-chamber carpules are used in medicine for the administration of preparations consisting of two components. There are two ways to combine the components, namely the combination liquid / liquid and the combination solid / liquid. Zweischkarpulen have the advantage that the mixing of the two components can be done without transferring to another container and that out of the container then directly administration can be done. Two-chamber carpules can be used in dedicated reusable syringe or pen systems.
  • EP 718002 and US 5,788,670 describe syringe barrel of bicameral syringes for two components to be applied, wherein a first part cylinder, preferably the head-side part of the cylinder containing an active substance to be lyophilized, and a second part cylinder, preferably the piston side part cylinder, a liquid component.
  • the powdery active ingredient mixes with the liquid component via a bypass.
  • the needle-side part cylinder contains the bypass and is closed with a plug at the proximal end.
  • the piston side sub-cylinder is with a stopper at the proximal, piston-side end ( Fig. 2 ) and optionally with another plug at the distal end ( Fig. 3 ) locked.
  • Both sub-cylinders are connected by means of cohesive (by welding) or non-positively (by gluing).
  • the syringe barrels described have a bypass, which is preferably shaped so that it does not increase the diameter of the syringe barrel.
  • the material of the front part of the cylinder is preferably plastic.
  • the syringe head of the first part cylinder is closed by a so-called tip cap, ie by a loose closure, through which the surrounding vacuum is passed on to the interior of the syringe barrel after being filled with the active ingredient to be lyophilized during the subsequent freeze-drying can, and that only after the lyophilization step is firmly closed.
  • the separate filling into a first and a second sub-cylinder avoids a "cross contamination" and allows optimal utilization of the process space of the lyophilizer.
  • the European patent application EP 520618 describes a prefilled syringe consisting of two sub-cylinders, wherein the first sub-cylinder, preferably the head-side sub-cylinder containing the needle or the outlet contains a lyophilized powdered drug, and the second sub-cylinder, preferably the piston-side sub-cylinder, a second, liquid component contains.
  • the powdered medicament mixes with the liquid component via a bypass.
  • the needle-side part cylinder contains the bypass and is closed with a plug at the proximal end.
  • the piston side sub-cylinder is closed with one stopper at the distal and at the proximal end.
  • Both sub-cylinders are sealed separately by means of the plugs and connected to one another via flanges, wherein the proximal plug of the head-side sub-cylinder and the distal plug of the piston-side sub-cylinder are positively connected to each other after assembly and the total length of both plugs is shorter than the length of the bypass.
  • GB 2010681 describes a two-chamber syringe for administering a liquid consisting of two sub-cylinders, wherein the first part-cylinder is formed as a needle holder and includes a channel to the outlet and the second, piston-side sub-cylinder contains liquid.
  • the first part cylinder contains no substance to be administered.
  • a plug with which the piston-side partial cylinder is closed at the distal end is moved in the direction of the syringe head, whereby the liquid can be applied via the channel of the first part-cylinder.
  • FR 1099362 describes a two-chamber syringes consisting of two sub-cylinders, wherein the first, head-side sub-cylinder, contains a sterile powder or a sterile liquid, and the second, piston-side sub-cylinder containing a liquid.
  • the sterile powder or the sterile liquid of the first part-cylinder mixes with the liquid of the second part-cylinder via a bypass in the first, needle-side part-cylinder.
  • the piston side sub-cylinder is closed with a plug on the distal and a piston on the proximal end.
  • Both sub-cylinders are connected by flanges or by means of another (over) cylinder whose inner diameter corresponds to the outer diameter of the two sub-cylinders by gluing or welding together.
  • the patent EP 0 397 977 A discloses a two-chamber carpule comprising a cylinder and an attachment, wherein the attachment is provided with radially extending through-holes, so that the liberated during a lyphilization solvent can escape via the through holes.
  • the syringe systems in the prior art have the disadvantage that they are not suitable for insertion into a syringe application (pen, etc.) due to the distal end designed with a needle holder and / or the solid active ingredient is first filled through a comparatively small opening as a solution or suspension must be and then lyophilized in the needle-side part cylinder to obtain a solid, powdery component.
  • no solution is mentioned in the prior art, according to which the pressure resulting from the joining of the two partial cylinders is compensated.
  • Object of the present invention is therefore to provide an improved two-chamber carpule and a to provide improved process for the production of two-chamber carpules and for filling Zweittingkarpulen ready.
  • the present invention relates to a two-chamber carpule according to claim 1.
  • the attachment forms the end of the cylinder (1) and is placed above (distal) of the bypass.
  • a dry active ingredient preparation (12) is filled in the head-side chamber (17).
  • Plug (6) can move properly over the seam. Cylinder and closure are tightly connected.
  • the cylinder may consist of one or two sub-cylinders.
  • the needle holder is a device for receiving a device to which a needle is attached.
  • the solid or liquid component of the anterior chamber and the liquid component of the posterior chamber form the drug to be administered.
  • the proximal end of the cylinder (1) preferably has a stop (13).
  • the stop prevents slipping of the end plug (10) by the resulting pressure during assembly in the direction of the proximal end.
  • the stopper is shaped so that the piston of an application system can transmit force to the end stopper.
  • Proximal means the end of a component which, when assembled, means the end stopper (10), ie the operator's piston or piston activating finger, when the two-chamber carpule is incorporated into a pen system and one at the end stopper (10). attacking plunger of the delivery system is actuated by the user's thumb.
  • the proximal end of the attachment is the end of the head which, when assembled, is connected to the distal end of the cylinder.
  • Distal means the end of a component that, when assembled, faces the outlet opening.
  • the "head end of the two-chamber carpule” is the end of the two-chamber carpule that forms the head of the two-chamber carpule, which thus contains the Austassötechnisch.
  • the "piston-side end of the two-chamber carpule" is the end of the two-chamber carpule on which the end plug (10) is located and on which the piston engages in an application system.
  • Plug and sealing elements are independent of each other of elastic material, for example rubber, preferably bromobutyl, chlorobutyl or fluorobutyl rubber.
  • the plugs are coated with PTFE.
  • the plugs are preferably cylindrical basic shape, but also other basic shapes corresponding to the inner shape of the sub-cylinders are possible.
  • the plugs have both a sealing and a closure function, for example, closes and seals intermediate plug (6) the chamber (18).
  • the sealing function is preferably ensured by one or more lamellar formations of the cylindrical basic shape.
  • Dense means the impermeability to solids, liquids, gases, as well as to germs.
  • the bypass (3) is an opening which, when using the two-chamber carpule, allows a liquid component (14) to flow from chamber (18) into chamber (17) during administration of the medicament, bypassing the intermediate plug (6).
  • the bypass (3) can be generated by one or more channels, which are located in the wall material of the sub-cylinder (1), that are embedded or incorporated into the wall material.
  • the bypass can also by appropriate shaping of the wall material to the inside (not shown) or to the outside (such as in FIG. 1a Shaped).
  • the arrangement may be designed to be axially or radially deviating from the axial direction.
  • Cylinder and attachment are formed independently from glass, plastic, metal or other materials, preferably transparent materials such as glass or plastic.
  • Plastics are preferably polycarbonates, polyesters, cyclo-olefin copolymers (COC) or cyclic olefin polymers (COP).
  • the medicament contains one or more pharmaceutically active ingredients selected from the group consisting of (i) a low molecular weight compound (having a molecular weight of up to 1,500 Da), (ii) a peptide, (iii) a protein, (iv) DNA, (v) RNA , (vi) antibodies, (vii) enzyme and (viii) oligonucleotide,
  • Insulin analogues are, for example, Gly (A21), Arg (B31), Arg (B32) - human insulin; Lys (B3), Glu (B29) - human insulin; Lys (B28), Pro (B29) - human insulin; Asp (B28) - human insulin; Human insulin, in which proline in the Position B28 has been substituted by Asp, Lys, Leu, Val or Ala and where in position B29 Lys may be substituted by Pro; Ala (B26) human insulin; Des (B28-B30) - human insulin; Des (B27) human insulin and Des (B30) human insulin.
  • Insulin derivatives are, for example, B29-N-myristoyl des (B30) human insulin; B29-N-palmitoyl-des (B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N- (N-palmitoyl-Y-glutamyl) des (B30) human insulin; B29-N- (N-lithocholyl-Y-glutamyl) des (B30) human insulin; B29-N- ( ⁇ -carboxyheptadecanoyl) -des (B30) human insulin and B29-N- ( ⁇ -carboxyh
  • Exendin-4 is preferably exendin-4 (1-39), a peptide having the sequence H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 ,
  • the pharmaceutically active ingredient is the solid component in the chamber of the front part cylinder, more preferably a lyophilisate or a powder.
  • Pharmaceutically acceptable salts include, for example, acid addition salts and basic salts.
  • Acid addition salts are, for example, HCl or HBr addition salts.
  • Basic salts are, for example, salts in which the cation is selected from the group of alkali metal salts, for example Na + or K + , or the alkaline earth metal salts, for example Ca 2+ , or ammonium ions N + (R 1 ) (R 2 ) (R 3 ) (R 4 ), where R 1 to R 4 independently of one another are hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 6 -C 10 -aryl, or C 6 -C 10 -heteroaryl.
  • R 1 to R 4 independently of one another are hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 6 -C 10 -aryl, or C 6 -C 10 -heteroaryl
  • Attachment and cylinder are connected in a manner known to those skilled form positive and / or non-positively, for example by screw, plug closure, bayonet, snap closure or clamp closure (shown in the figures).
  • the compound is preferably self-sealing or is accomplished for example by gluing or welding.
  • a sealing element can be used.
  • the cylinder (1) is the female component. If head (2) and cylinder (1) are connected to one another, for example by screw-type closure, the cylinder (1) has an internal thread at the distal end, and head (2) has a corresponding external thread at the proximal end.
  • head (2) is the female component. If the head (2) and cylinder (1) are connected to one another, for example by screw closure, the head (2) has an internal thread at the proximal end, and the cylinder (1) has a corresponding external thread at the distal end.
  • the closure consists of an integrated closure cap which can be formed with and without a shoulder.
  • the attachment preferably includes a sealing element for sealing the distal end of the integral closure and another sealing element for sealing the connection between the integral closure and the cylinder.
  • the sealing element is a sealing ring in the case of a cylindrical cross-section of cylinder and closure.
  • a one-piece, integrated cap (22) with a distal opening for placement on the cylinder (1) and further comprising a sealing element for sealing the distal end of the integrated cap (22) and optionally (preferably) another sealing element ( 7) for sealing the connection between the integrated cap (22) and cylinder (1).
  • the integrated cap (22) is shaped so that slipping of the sealing element in the axial and transverse direction is prevented.
  • the connection of the cylinder and integrated closure cap preferably takes place via a crimp closure, wherein the integrated closure cap engages in a radial groove at the distal end of the cylinder (1).
  • Another example of a connection is the screw cap.
  • the article consists of a one-piece closure element (16) characterized by a crimp cap with a distal opening for placement on the cylinder (1) and a sealing element (15) for sealing the distal end of the closure element (16) and Sealing the connection between closure element (16) and cylinder (1).
  • the closure element (16) is shaped so that slipping of the sealing element in the axial and transversal direction is prevented.
  • the connection of cylinder (1) and closure element (16) preferably takes place via a crimp closure, closure element (16) engaging in a radial groove at the distal end of the cylinder (1).
  • Another example of a connection is the screw cap.
  • the attachment consists of a one-piece closure element (16) with a distal opening, a sealing element (15) for sealing the distal end of the closure element (16) and sealing the connection between closure element (16) and cylinder (1).
  • the cylinder (1) has a substantially cylindrical body and a distal portion with a reduced diameter relative to the diameter of the body, which is provided with a distal opening suitable for piercing with an applicator needle and optionally a needle holder.
  • the main body tapers over a shoulder to the portion of reduced diameter.
  • the diameter of the distal opening is preferably 6-10 mm, more preferably 6-9 mm, especially preferably 7-9 mm.
  • the diameter of the distal opening may be 6-9 mm, preferably 6-7 mm, for an outside diameter of the cylinder (1) of 9-15 mm.
  • the distal opening ensures easy filling of the carpule with the dry preparation of active compound, in particular with a powder.
  • the closure element (16) is shaped so that slipping of the sealing element in the axial and transversal direction is prevented.
  • the connection of cylinder (1) and closure element (16) preferably takes place via a crimp closure, wherein closure element (16) engages over a bead at the distal end of the section.
  • Another example of a connection of cylinder (1) and closure element (16) is the screw cap.
  • the closure is designed in two pieces.
  • the two-piece embodiment includes a sealing element for sealing the distal end of the closure and another for sealing the connection between the closure and the cylinder.
  • the sealing element for sealing the connection between the closure and the cylinder is, for example, a sealing ring in the case of a cylindrical cross-section of cylinder and closure.
  • the sealing member for sealing the distal end of the closure is preferably a sealing washer.
  • the closure consists of a head (2) and a closure cap (5).
  • the attachment thus consists of a head (2) and a closure cap (5) with a distal opening suitable for piercing with an application needle and optionally a needle holder, a sealing element for sealing the connection between head (2) and closure cap (5) and optionally another Sealing element (7) for sealing the connection between the head (2) and cylinder (1).
  • the connection of cylinder and head is preferably carried out by engagement of the head (2) in the cylinder (1) or by engagement of the cylinder (1) in the head (2).
  • the head (2) has at the proximal end a geometry compatible with the distal end of the cylinder (1), for example, in the case of a cylindrical basic shape of the cylinder (1), a diameter compatible with the distal end of the cylinder.
  • Cylinder (1) is preferably of zylinderischer basic shape and particularly preferably has a substantially constant over the entire length diameter.
  • the head and cylinder are particularly preferably connected to one another by means of a clamp closure or, in particular, in the case of a cylindrical geometry by means of a screw cap.
  • the closure is designed in three pieces.
  • the three-piece embodiment includes a sealing element for sealing the distal end of the closure and another for sealing the connection between the closure and the cylinder.
  • the sealing element for sealing the connection between the closure and the cylinder is, for example, a sealing ring in the case of a cylindrical cross-section of cylinder and closure.
  • the sealing member for sealing the distal end of the closure is preferably a sealing washer.
  • the closure preferably consists of a head (2), a head holder (19) and a closure cap (5).
  • the attachment thus consists of a head (2), a head holder (19) and a closure cap (5) with a distal opening suitable for piercing with an application needle and optionally a needle holder, a sealing element for sealing the connection between head (2) and closure cap ( 5) and optionally a further sealing element (7) for sealing the connection between the head (2) and the cylinder (1).
  • the connection of cylinder and closure preferably takes place via a crimp closure, wherein the head holder (19) engages in a radial groove at the distal end of the cylinder (1).
  • Another example of a connection is the screw cap.
  • a transverse movement of the head relative to the cylinder is prevented by engagement of the head (2) in the cylinder (1) or by engagement of the cylinder (1) in the head (2).
  • the cap (5) is a device that seals the distal end of the head (2).
  • the cap is made of aluminum or a plastic and ensures permanent connection and sealing force with the head (2).
  • the compound can be prepared by methods known to those skilled in the art, for example by crimping, crimping, bouncing or screwing.
  • either the proximal end of the head (2) or the distal end of the cylinder (1) includes an axial groove (11) on the inside of the female component.
  • a pressure in chamber (17) may build up, which could push out the intermediate stopper (6) and possibly also the end plug (10).
  • the pressure can be largely avoided by the axial groove (11), as initially air can escape during assembly.
  • the groove is shaped to have a length axially less than the length of engagement of the proximal end of the male component with the corresponding end of the female component.
  • the groove is formed so that it further reduces the wall thickness of the female component. For example, like in FIG.
  • the axial groove (11) may be at the proximal end of the head (2) or at the distal end of the cylinder (1); Preferably, the axial groove (11) is at the distal end of the cylinder (1).
  • the two-chamber carpule includes an axial groove (11) in the cylinder (1) and a stop (13) at the proximal end of the cylinder (1).
  • cylinder (1) and head (2) are made of plastic.
  • both plastic components are connected to one another via a screw closure, wherein a sealing element is optionally inserted for sealing between the sub-cylinders.
  • the distal end of the cylinder (1) includes an axial groove (11) through which the pressure built up in the chamber (17) can escape during the assembly of the two components; alternatively, the intermediate plug (6) and the end plug (10) be positioned in the cylinder (1) so that both are moved during assembly by the pressure built up in the desired end position.
  • Cylinder (1) preferably contains a stop (13) at the proximal end.
  • the cylinder (1) consists of glass and the head (2) of plastic, which are particularly preferably connected to one another via a clamp closure.
  • the sealing of the sub-cylinders can be done by bonding using conventional pharmatau réelle adhesive, optionally between the cylinder and head, a sealing element is inserted.
  • the distal end of the cylinder (1) includes an axial groove (11) through which the pressure built up in the chamber (17) can escape during the assembly of the two components;
  • the intermediate plug (6) and the end plug (10) can be positioned in the cylinder (1) so that both are moved to the desired end position during assembly by the built-up pressure.
  • Cylinder (1) preferably contains a stop (13) at the proximal end.
  • both cylinders (1) and head (2) are made of plastic and are connected to one another via a plug-in closure, wherein a sealing element is optionally inserted for sealing between the partial cylinders.
  • the distal end of the cylinder (1) includes an axial groove (11) through which the pressure built up in the chamber (17) can escape during the assembly of the two components;
  • the intermediate plug (6) and the end plug (10) can be positioned in the cylinder (1) so that both are moved to the desired end position during assembly by the built-up pressure.
  • Cylinder (1) preferably contains a stop (13) at the proximal end.
  • Head holder (19) consists for example of metal or plastic, preferably of aluminum.
  • liquid component (14) and the solid component (12) are preferably filled under sterile conditions.
  • the two-chamber carpule according to the invention has the advantage that the cylinder can be filled through the entire diameter of the partial cylinder, and that the attachment can be placed on the contact points between the components after filling the chamber (17) without risk of contamination by the liquid component (14).
  • the filling over large openings ensures a reduced likelihood of contamination of the other sub-cylinder or the carpule outside. Since powders can be filled directly, no lyophilization is necessary. Instead, a lyophilisate (the product of a lyophilization) or another solid component, preferably in powder form, can be directly charged.
  • the gentle powder filling also ensures that no influence on the crystalline structure of the powder via shear forces occur, as they can occur during filling through small openings, so that no influence on the bioavailability of the drugs to be administered is to be expected. Furthermore, the location of the separation of the two components cylinder and attachment in the region of the head-side chamber (17), so that when powder filling a sterile process can be ensured easily. By setting the middle plug after filling the piston-side chamber (18), a risk of contamination of both components (12) and (14) is excluded.
  • the two-chamber carpule according to the invention can be used in any application system, for example a pen system, wherein the application system preferably includes a needle for piercing a distal sealing disc, and a drive mechanism for moving the end plug (10) in the distal direction.
  • the application system preferably includes a needle for piercing a distal sealing disc, and a drive mechanism for moving the end plug (10) in the distal direction.
  • cylinder (1) and head (2) are injection-molded in the clean room, then sterilized in hermetic packaging.
  • plastic as a material for the sub-cylinder also ensures the cost-effective production of the parts, the integration of functional parts to one of the sub-cylinders, which are required for operating a pen system (synergies), a simple process for the production of particle freedom, sterilization , Depyrogenation, high dimensional stability and recyclability.
  • the invention further relates to an application device comprising a two-chamber carpule as described above.
  • the components of the two-chamber carpule are as defined above in their general and preferred embodiments.
  • the center plug prior to inserting the end plug, is positioned so that the pressure build-up shifts the center plug to the desired end position.
  • the center plug can in principle be introduced from both ends of the cylinder.
  • cylinder and attachment are assembled under vacuum conditions. By this measure, a displacement of the plug is largely avoided.
  • the proximal end of the head holder (19) can be provided with a radial groove (20) at the distal end (8) of the head holder Cylinder be crimped.
  • the attachment is formed from a one-piece closure element (16) and a sealing washer (15), the proximal end of the closure element (16) may be crimped with a radial groove (20) at the distal end (8) of the cylinder.
  • the closure is formed as an integral closure cap (22), the proximal end of the integral closure cap (22) may be crimped with a radial groove (20) at the distal end (8) of the cylinder.
  • FIGS. 1 a and 1b show the basic structure of the invention as an exploded view ( FIG. 1 a) and in the assembled state ( Figure 1 b).
  • Figure 1 c shows the structure of a non-inventive cap (5). This structure corresponds to the structure of a one-piece closure element.
  • FIGS. 2a to 2c show the connection of the head (2) with the cylinder (1) by crimping over a head holder (19).
  • FIG. 2b shows a pre-assembled head with cap (21), upper part.
  • FIG. 3a shows a non-inventive integrated cap (22) which can be attached by crimp on the cylinder ( FIG. 3b).
  • FIG. 3b shows the integrated cap (22) in the cylinder-connected state (crimped).
  • FIG. 4a shows as a one-piece attachment a non-inventive closure element (16) and a sealing washer (15).
  • FIG. 4b shows the non-inventive one-piece closure element (16) and the sealing disc (15) connected to the cylinder state (crimped).
  • FIG. 5 shows the upper part of a two-chamber carpule with a further embodiment of a non-inventive one-piece attachment as a closure element (16), a cylinder (1) and a sealing washer (15), wherein the cylinder (1) has a substantially cylindrical body and a distal portion with a has reduced diameter relative to the diameter of the body, which is provided with a distal opening suitable for piercing with an applicator needle and optionally a needle holder.
  • the closure element (16) is crimped over a bead of the cylinder.
  • FIG. 6a-7d show a method for filling the two-chamber carpule according to the invention.
  • FIG. 6a shows the insertion of the center plug (6) in the cylinder (1).
  • FIG. 6b shows the filling of the piston-side chamber (18) with a liquid carrier medium (14).
  • FIG. 6c shows the closing of the chamber (18) with the end plug (10).
  • FIG. 6d shows cylinder (1) with center stopper (6), end stopper (10) and filled piston-side chamber (18).
  • Figure 7a shows the rotated for further processing cylinder (1) with center stopper (6), end plug (10) and filled piston-side chamber (18), in which the head-side end facing upward.
  • FIG. 7b shows the introduction of the dry preparation of active compound (12).
  • FIG. 7c shows the placement of the head (2), cap (5) and sealing element (7) at the distal end (8) of the cylinder to the serviceable, closed two-chamber carpule.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Nozzles (AREA)
  • Pens And Brushes (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Claims (8)

  1. Ampoule à deux chambres, constituée
    a) d'un cylindre contenant
    un bouchon d'extrémité qui est positionné sur l'extrémité proximale du cylindre, en option, une butée (13) sur l'extrémité proximale (9),
    un bouchon intermédiaire (6),
    une dérivation (3),
    une extrémité distale (8) destinée à être assemblée avec une garniture et
    b) de la garniture constituée
    d'une fermeture avec un orifice distal adapté pour être percé à l'aide d'une aiguille d'application et, en option, d'un porte-aiguille,
    d'un ou de plusieurs éléments d'étanchéité pour assurer l'étanchéité de l'extrémité distale de la fermeture et/ou pour assurer l'étanchéité de la liaison entre la fermeture et le cylindre, caractérisée en ce
    que la fermeture est conçue en deux pièces ou en trois pièces et
    qu'une extrémité proximale de la garniture est l'extrémité d'une tête qui, à l'état assemblé, est reliée à l'extrémité distale du cylindre, une rainure axiale (11) étant prévue sur l'extrémité proximale de la tête ou sur l'extrémité distale du cylindre, sur la face intérieure de l'élément de réception.
  2. Ampoule à deux chambres selon la revendication 1, la garniture étant constituée de la tête (2) et d'un capuchon de fermeture (5) avec un orifice distal adapté pour être percé à l'aide d'une aiguille d'application et, en option, d'un porte-aiguille, d'un élément d'étanchéité pour assurer l'étanchéité de la liaison entre la tête (2) et le capuchon de fermeture (5) et, en option, d'un élément d'étanchéité (7) supplémentaire pour assurer l'étanchéité de la liaison entre la tête (2) et le cylindre (1).
  3. Ampoule à deux chambres selon la revendication 1, la garniture étant constituée de la tête (2), d'un support de tête (19) et d'un capuchon de fermeture (5) avec un orifice distal adapté pour être percé à l'aide d'une aiguille d'application et, en option, d'un porte-aiguille, d'un élément d'étanchéité pour assurer l'étanchéité de la liaison entre la tête (2) et le capuchon de fermeture (5) et, en option, d'un élément d'étanchéité (7) supplémentaire pour assurer l'étanchéité de la liaison entre la tête (2) et le cylindre (1).
  4. Ampoule à deux chambres selon l'une quelconque des revendications 1 à 3,
    l'extrémité proximale du cylindre (1) comportant une butée (13).
  5. Ampoule à deux chambres selon l'une quelconque des revendications 1 à 4,
    l'ampoule à deux chambres comportant un médicament à administrer et le médicament à administrer étant un peptide pour le traitement du diabète mellitus ou de complications du diabète mellitus.
  6. Ampoule à deux chambres selon la revendication 5, le peptide étant de l'Exendine-4(1-39) ou un peptide choisi dans le groupe
    H-(Lys)4-du Pro36, du Pro37 Exendine-4(1-39)-NH2,
    H-(Lys)5-du Pro36, du Pro37 Exendine-4(1-39)-NH2,
    du Pro36 [Asp28] Exendine-4(1-39),
    du Pro36 [IsoAsp28] Exendine-4(1-39),
    du Pro36 [Met(O)14, Asp28] Exendine-4(1-39),
    du Pro36 [Met(O)14, IsoAsp28] Exendine-4 (1-39),
    du Pro36 [Trp(O2)25, Asp28] Exendine-4(1-39),
    du Pro36 [Trp(O2)25, IsoAsp28] Exendine-4(1-39),
    du Pro36 [Met(O)14 Trp(O)25, Asp28 Exendine-4(1-39),
    du Pro36 [Met(O)14 Trp(O)25, IsoAsp28] Exendine-4(1-39), H-(Lys)6- du Pro36 [Asp28] Exendine-4(1-39)-Lys6-NH2,
    de l'Asp28 Pro36, Pro37, Pro38 Exendine-4(1-39)-NH2, H-(Lys)6- du Pro36, Pro38 [Asp28] Exendine-4(1-39)-NH2,
    H-Asn-(Glu)5 du Pro36, Pro37, Pro38 [Asp28] Exendine-4 (1-39)-NH2,
    du Pro36, Pro37, Pro38 [Asp28] Exendine-4(1-39)-(Lys) 6-NH2,
    H-(Lys)6- du Pro36, Pro37 Pro38 [Asp28] Exendine-4(1-39) - (Lys) 6-NH2,
    H-Asn-(Glu)5- du Pro36, Pro37, Pro38 [Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-(Lys)6- du Pro36 [Trp(O2)25, Asp28] Exendine-4 (1-39) -Lys6-NH2,
    H- de l'Asp28 Pro36, Pro37, Pro38 [Trp(O2)25] Exendine-4(1-39)-NH2,
    H-(Lys)6- du Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendine-4(1-39)-NH2,
    H-Asn-(Glu)5- du Pro36, Pro37, Pro38 [Trp(O)25,
    Asp28] Exendine -4(1-39)-NH2,
    du Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendine-4 (1-39)-(Lys) 6-NH2,
    H-(Lys)6,- du Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-Asn-(Glu)5- du Pro36 Pro37 Pro38 [Trp(O2)25, Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-(Lys)6- du Pro36 [Met(O)14, Asp28] Exendine-4(1-39) -Lys6-NH2,
    du Met(O)14 Asp28 Pro36, Pro37, Pro38 Exendine-4(1-39)-NH2, H-(Lys)6 du Pro36, Pro37, Pro38 [Met(O)14,
    Asp28] Exendine-4(1-39)-NH2,
    H-Asn-(Glu)5- du Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendine-4(1-39)-NH2,
    du Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendine-4(1-39) - (Lys) 6-NH2,
    H-(Lys)6- du Pro36, Pro37, Pro38 [Met(O)14 Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-Asn-(Glu)5 du Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-Lys6- du Pro36 [Met(O)14, Trp(O2)25, Asp28] Exendine-4(1-39)-Lys6-NH2,
    H- de l'Asp28 Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25] Exendine-4(1-39)-NH2,
    H-(Lys)6- du Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendine-4(1-39)-NH2,
    H-Asn-(Glu)5- du Pro36, Pro37, Pro38 [Met(O)14,
    Trp(O2)25, Asp28] Exendine-4(1-39)-NH2,
    du Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendine-4(1-39)-(Lys)6-NH2,
    H-(Lys)6- du Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendine-4 (S1-39)-(Lys) 6-NH2,
    H-Asn-(Glu)5- du Pro36, Pro37, Pro38 [Met(O)14,
    Trp(O2)25, Asp28] Exendine-4(1-39)-(Lys)6-NH2; ou
    du Pro36 [Asp28] Exendine-4(1-39),
    du Pro36 [IsoAsp28] Exendine-4(1-39),
    du Pro36 [Met(O)14, Asp28] Exendine-4(1-39),
    du Pro36 [Met(O)14, IsoAsp28] Exendine-4(1-39),
    du Pro36 [Trp(O2)25, Asp28] Exendine-4(1-39),
    du Pro36 [Trp(O2)25, IsoAsp28] Exendine-4(1-39),
    du Pro36 [Met(O)14 Trp(O2)25, Asp28] Exendine-4 (1-39),
    du Pro36 [Met(O)14 Trp(O2)25, IsoAsp28 Exendine-4 (1-39),
    le groupe -Lys6-NH2 étant enchaîné avec le terminus C du dérivé d'Exendine-4 ;
    ou un sel ou solvate acceptable du point de vue pharmaceutique de ce dernier.
  7. Instrument d'application contenant une ampoule à deux chambres selon l'une quelconque des revendications 1 à 6.
  8. Procédé de fabrication et de remplissage d'une ampoule à deux chambres selon l'une quelconque des revendications 1 à 6, caractérisé en ce que
    a) on munit un cylindre contenant une dérivation d'un bouchon central entre la dérivation et l'extrémité proximale ;
    b) on remplit la chambre d'un composant liquide entre le bouchon central et l'extrémité proximale ;
    c) on ferme à l'aide d'un bouchon d'extrémité la chambre contenant le composant liquide ;
    d) on remplit la chambre d'un composant liquide ou de préférence solide entre le bouchon central et l'extrémité distale du cylindre ; et
    e) on ferme l'extrémité distale du cylindre avec une garniture.
EP08758924.8A 2007-06-14 2008-05-31 Carpule à double chambre dotée d'un chapiteau Active EP2167169B2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08758924.8A EP2167169B2 (fr) 2007-06-14 2008-05-31 Carpule à double chambre dotée d'un chapiteau

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07011687 2007-06-14
PCT/EP2008/004355 WO2008151736A1 (fr) 2007-06-14 2008-05-31 Ampoule à deux chambres avec garniture
EP08758924.8A EP2167169B2 (fr) 2007-06-14 2008-05-31 Carpule à double chambre dotée d'un chapiteau

Publications (3)

Publication Number Publication Date
EP2167169A1 EP2167169A1 (fr) 2010-03-31
EP2167169B1 EP2167169B1 (fr) 2012-05-23
EP2167169B2 true EP2167169B2 (fr) 2016-03-09

Family

ID=38621207

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08758924.8A Active EP2167169B2 (fr) 2007-06-14 2008-05-31 Carpule à double chambre dotée d'un chapiteau

Country Status (9)

Country Link
US (2) US8092422B2 (fr)
EP (1) EP2167169B2 (fr)
JP (1) JP2010528791A (fr)
CN (1) CN101678175A (fr)
AR (1) AR066986A1 (fr)
DK (1) DK2167169T4 (fr)
ES (1) ES2386166T5 (fr)
TW (1) TW200916140A (fr)
WO (1) WO2008151736A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3016451A1 (fr) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Combinaison d'une insuline et d'un agoniste de glp-1
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
US20140148384A1 (en) 2010-08-30 2014-05-29 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HUE027989T2 (en) 2011-08-29 2016-11-28 Sanofi Aventis Deutschland A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US9751056B2 (en) 2012-01-23 2017-09-05 Merit Medical Systems, Inc. Mixing syringe
US8834449B2 (en) 2012-01-23 2014-09-16 Ikomed Technologies, Inc. Mixing syringe
US8870028B2 (en) 2012-05-25 2014-10-28 Restek Corporation Dispensing device
WO2014093926A1 (fr) 2012-12-14 2014-06-19 Larson Bryan Carpule de médicament double pour seringues dentaires
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
ITRM20130457A1 (it) * 2013-08-05 2015-02-06 Orofino Pharmaceuticals Group Srl Prodotto intermedio per la realizzazione di siringhe o cartucce a doppia camera pre-riempite e procedimento di produzione di detto prodotto intermedio
USD755957S1 (en) 2013-12-13 2016-05-10 Bryan Larson Dental carpule
CN112957455A (zh) 2014-01-09 2021-06-15 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
BR112016013832A2 (pt) 2014-01-09 2017-08-08 Sanofi Sa Uso de análogo e/ou derivado de insulina, formulação farmacêutica e processo para a preparação da mesma, kit e dispositivo médico
US10376649B2 (en) 2014-10-29 2019-08-13 Wockhardt Limited Drug delivery device for delivery of two or more independently user selectable multiple doses of medicaments with user operable variable dose locking mechanisms
HUE062573T2 (hu) 2014-12-12 2023-11-28 Sanofi Aventis Deutschland Glargin inzulin/lixiszenatid rögzített arányú készítmény
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
TWI746569B (zh) 2016-06-08 2021-11-21 瑞士商瑞健醫療股份有限公司 計量器具、注射裝置、及其應用
CN109996576A (zh) 2016-11-28 2019-07-09 爱杜西亚制药有限公司 用于输注物质的装置
DE102017208255A1 (de) * 2017-05-16 2018-11-22 Vetter Pharma-Fertigung GmbH & Co. KG Medikamentenbehälter mit einem Endstopfen, Verwendung eines Stopfensicherungsteils zum Sichern eines Endstopfens in einem Medikamentenbehälter und Stopfensicherungsteil

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705392A (en) † 1951-03-14 1954-03-10 Frank Myles Turnbull Improvements relating to hypodermic injection apparatus
US2880725A (en) † 1954-06-11 1959-04-07 Becton Dickinson Co Syringe assembly
US3102539A (en) † 1960-11-23 1963-09-03 Graham Chemical Corp Disposable cartridge type hypodermic syringe devices
DE2163668A1 (de) † 1971-12-21 1973-07-05 Paul Apolo Dr Med Jordana Spritze oder spritzflasche, insbesondere fuer heil- und hygienische zwecke
FR2178019A1 (en) † 1972-03-28 1973-11-09 Inveco Waalwijk Bv Injection syringe - filled during mfre
DE2439312A1 (de) † 1973-08-16 1975-04-03 Kyburz Hans Ampulle fuer arzneimittel
US4226236A (en) † 1979-05-07 1980-10-07 Abbott Laboratories Prefilled, vented two-compartment syringe
US4254768A (en) † 1979-09-14 1981-03-10 Ty Perla J Hypodermic syringe
EP0302248B1 (fr) † 1987-07-21 1991-10-23 WASSERBURGER ARZNEIMITTELWERK DR. MADAUS GMBH & CO. KG Seringue à injection pour usage médical
EP0248210B1 (fr) † 1986-05-02 1991-11-06 Sunstar Kabushiki Kaisha Seringue
US5069670A (en) † 1989-05-17 1991-12-03 Arzneimittel Gmbh Apotheker Vetter & Co. Hypodermic syringe
WO1992001485A1 (fr) † 1990-07-20 1992-02-06 Novo Nordisk A/S Seringue a deux compartiments
EP0520618A2 (fr) † 1991-06-26 1992-12-30 Arte Corporation Seringue préremplie à double compartiment
US6261094B1 (en) † 2000-04-19 2001-07-17 Centrix, Inc. Dental capsule for placement of ultra-high viscosity dental composite material
WO2002039920A1 (fr) † 2000-11-15 2002-05-23 Sdi Limited Capsule dentaire
US20030199816A1 (en) † 2002-04-17 2003-10-23 Scott Ramming Pre-loaded multi-chamber syringe
EP1728560A1 (fr) † 2005-06-03 2006-12-06 3M Innovative Properties Company Système de stockage et de distribution d'une substance
DE102005038495A1 (de) † 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Doppelkammer-Behälter und Verfahren zu dessen Befüllung
DE102005038458A1 (de) † 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Doppelkammer-Behälter ohne Bypass im zylindrischen Körper

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL180634C (nl) 1977-12-23 1987-04-01 Duphar Int Res Injectiespuit alsmede naaldhouder hiervoor.
NZ247392A (en) * 1992-04-30 1995-05-26 Takeda Chemical Industries Ltd Prefilled syringe containing two substances mixed before injection
DE4445969C1 (de) 1994-12-22 1996-03-14 Schott Glaswerke Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
FR2749169B1 (fr) * 1996-06-04 1998-08-21 Delab Procede pour constituer une preparation injectable et dispositif pour la mise en oeuvre de ce procede
JP4399752B2 (ja) * 1999-07-06 2010-01-20 日本ケミカルリサーチ株式会社 薬剤溶解機構内蔵注射器
JP2001112867A (ja) * 1999-10-18 2001-04-24 Terumo Corp 薬剤入りシリンジ
DE10140704A1 (de) * 2001-08-18 2003-03-06 Vetter & Co Apotheker Verfahren zur Durchmischung einer schwer löslichen pharmazeutischen Substanz mit einem Lösungsmittel und Spritze zur Anwendung des Verfahrens
US20060173409A1 (en) * 2004-12-28 2006-08-03 Chang-Ming Yang Safety syring

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705392A (en) † 1951-03-14 1954-03-10 Frank Myles Turnbull Improvements relating to hypodermic injection apparatus
US2880725A (en) † 1954-06-11 1959-04-07 Becton Dickinson Co Syringe assembly
US3102539A (en) † 1960-11-23 1963-09-03 Graham Chemical Corp Disposable cartridge type hypodermic syringe devices
DE2163668A1 (de) † 1971-12-21 1973-07-05 Paul Apolo Dr Med Jordana Spritze oder spritzflasche, insbesondere fuer heil- und hygienische zwecke
FR2178019A1 (en) † 1972-03-28 1973-11-09 Inveco Waalwijk Bv Injection syringe - filled during mfre
DE2439312A1 (de) † 1973-08-16 1975-04-03 Kyburz Hans Ampulle fuer arzneimittel
US4226236A (en) † 1979-05-07 1980-10-07 Abbott Laboratories Prefilled, vented two-compartment syringe
US4254768A (en) † 1979-09-14 1981-03-10 Ty Perla J Hypodermic syringe
EP0248210B1 (fr) † 1986-05-02 1991-11-06 Sunstar Kabushiki Kaisha Seringue
EP0302248B1 (fr) † 1987-07-21 1991-10-23 WASSERBURGER ARZNEIMITTELWERK DR. MADAUS GMBH & CO. KG Seringue à injection pour usage médical
US5069670A (en) † 1989-05-17 1991-12-03 Arzneimittel Gmbh Apotheker Vetter & Co. Hypodermic syringe
WO1992001485A1 (fr) † 1990-07-20 1992-02-06 Novo Nordisk A/S Seringue a deux compartiments
EP0520618A2 (fr) † 1991-06-26 1992-12-30 Arte Corporation Seringue préremplie à double compartiment
US6261094B1 (en) † 2000-04-19 2001-07-17 Centrix, Inc. Dental capsule for placement of ultra-high viscosity dental composite material
WO2002039920A1 (fr) † 2000-11-15 2002-05-23 Sdi Limited Capsule dentaire
US20030199816A1 (en) † 2002-04-17 2003-10-23 Scott Ramming Pre-loaded multi-chamber syringe
EP1728560A1 (fr) † 2005-06-03 2006-12-06 3M Innovative Properties Company Système de stockage et de distribution d'une substance
DE102005038495A1 (de) † 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Doppelkammer-Behälter und Verfahren zu dessen Befüllung
DE102005038458A1 (de) † 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Doppelkammer-Behälter ohne Bypass im zylindrischen Körper

Also Published As

Publication number Publication date
AR066986A1 (es) 2009-09-23
US20100274186A1 (en) 2010-10-28
WO2008151736A1 (fr) 2008-12-18
US8092422B2 (en) 2012-01-10
TW200916140A (en) 2009-04-16
CN101678175A (zh) 2010-03-24
EP2167169A1 (fr) 2010-03-31
ES2386166T3 (es) 2012-08-10
DK2167169T4 (en) 2016-05-30
DK2167169T3 (da) 2012-09-03
JP2010528791A (ja) 2010-08-26
EP2167169B1 (fr) 2012-05-23
US20120078171A1 (en) 2012-03-29
ES2386166T5 (es) 2016-06-21

Similar Documents

Publication Publication Date Title
EP2167169B2 (fr) Carpule à double chambre dotée d'un chapiteau
EP2155303A1 (fr) Ampoule à deux chambres
EP2224982B1 (fr) Système de seringue à deux chambres comportant une membrane perméable aux gaz
DE4445969C1 (de) Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
AT500930B1 (de) Verfahren und vorrichtung zum lyophilisieren, rekonstituieren und verabreichen eines rekonstituierten wirkstoffes
DE69502357T2 (de) Injektionsmodul für eine spritze
DE69823481T2 (de) Wegwerfbare, vorgefüllte medikamentenkartusche
DE19652708C2 (de) Verfahren zum Herstellen eines befüllten Kunststoff-Spritzenkorpus für medizinische Zwecke
EP2445552B1 (fr) Appareil d administration à fonction d amorçage
DE3885018T2 (de) Injektionsspritze.
AT391271B (de) Injektionsspritze
WO2007020237A1 (fr) Contenant a deux chambres sans derivation dans le corps cylindrique
WO2007020239A1 (fr) Contenant a deux chambres et procede pour le remplir
DE10203598A1 (de) Injektionsgerät mit steril montierter Injektionsnadel sowie Nadelträger und Ampulle für solch ein Injektionsgerät
DE2854527A1 (de) Injektionsspritze
DE2455509A1 (de) Zweikammermischspritze
DE202011110696U1 (de) Kodierte Kartuschenbaugruppe
DE202010018605U1 (de) Kartuschenhalter und Medikamentenabgabevorrichtung
EP3976139A1 (fr) Corps médical creux, corps médical creux doté d'un capuchon de fermeture, procédé de fabrication d'un corps médical creux, et kit
DE2329390A1 (de) Injektionsspritze
EP4374896A1 (fr) Unité d'entraînement pour une seringue médicale, seringue comprenant une telle unité d'entraînement et auto-injecteur
EP4119173A1 (fr) Coiffe de fermeture et système de fermeture pour une seringue préremplie d'un médicament ou d'un principe actif médical
WO2022053166A1 (fr) Seringue médicale avec protection d'aiguille
DE1491850C (de) Spritzampulle

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

17Q First examination report despatched

Effective date: 20100323

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 558754

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008007265

Country of ref document: DE

Effective date: 20120719

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2386166

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20120810

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20120525

Year of fee payment: 5

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20120523

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

Effective date: 20120523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120823

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120923

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120924

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120824

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: VETTER PHARMA-FERTIGUNG GMBH & CO. KG

Effective date: 20130220

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E015256

Country of ref document: HU

REG Reference to a national code

Ref country code: DE

Ref legal event code: R026

Ref document number: 502008007265

Country of ref document: DE

Effective date: 20130220

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120523

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120823

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20130924

Year of fee payment: 6

Ref country code: HU

Payment date: 20130923

Year of fee payment: 6

Ref country code: MC

Payment date: 20130926

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20130923

Year of fee payment: 6

Ref country code: LU

Payment date: 20131007

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20131004

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140602

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140531

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

APBM Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNO

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20160309

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R102

Ref document number: 502008007265

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: AELC

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: DK

Ref legal event code: T4

Effective date: 20160527

REG Reference to a national code

Ref country code: ES

Ref legal event code: DC2A

Ref document number: 2386166

Country of ref document: ES

Kind code of ref document: T5

Effective date: 20160621

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: RU

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140531

REG Reference to a national code

Ref country code: FR

Ref legal event code: D7

Effective date: 20170724

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20180514

Year of fee payment: 11

Ref country code: ES

Payment date: 20180601

Year of fee payment: 11

Ref country code: CZ

Payment date: 20180515

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20180618

Year of fee payment: 6

Ref country code: AT

Payment date: 20180426

Year of fee payment: 11

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20190531

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 558754

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20201002

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140531

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230421

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240328

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240402

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240328

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20240602

Year of fee payment: 17